NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

OrthoPediatrics Corp. Common Stock (KIDS) Stock Analysis

OrthoPediatrics Corp. Common Stock (KIDS) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

KIDS

$22.41

−$0.18 (−0.80%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare KIDS with… →

KIDS Key Statistics

As of Sep 4, 2026
Trading
Open
$22.29
Previous Close
$22.59
Day's Range
21.93–22.56
52-Week Range
14.42–26.74
Volume
129.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.98
Valuation
Market Cap
$585.12M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.32
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.67
Financials (FY)
Revenue (FY)
$236.35M+15.45%
Net Income (FY)
−$39.65M
Profit marginThe share of revenue left as profit after all costs and taxes.
−15.72%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
26.11M
1-Year Return
+8.21%
Dividend and dates
Earnings Date
October 28, 2026estimated
Avg Volume
195.75K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KIDS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+26.18%
2025−23.38%
2024−28.70%
2023−18.17%
2022−33.63%
2021+45.12%
2020−12.22%
2019+34.72%
2018+81.76%
2017 (partial year)+2.35%

As of September 4, 2026.

KIDS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$236.35M−$39.65M−16.8%
2024$204.73M−$37.82M−18.5%
2023$148.73M−$20.97M−14.1%
2022$122.29M$1.26M1.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$236.35M$172.66M−$29.00M−$39.65M−16.8%
2024$204.73M$148.60M−$29.52M−$37.82M−18.5%
2023$148.73M$111.25M−$25.77M−$20.97M−14.1%
2022$122.29M$90.66M−$21.79M$1.26M1.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

KIDS Valuation vs Medical Devices Median

Median of 151 stocks
MetricKIDSMedical Devices medianvs median
P/S ratio2.322.9822% below
Profit margin−15.72%−1.69%14.0 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 10 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values OrthoPediatrics Corp. Common Stock (KIDS) at $585.12M. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 602.

The 52-week range on file runs from $14.42 to $26.74. KIDS last closed at $22.41 on September 4, 2026. That is −$0.18 (−0.80%) against the previous close. The latest close sits 55.41% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $236.35M. That is +15.45% against the prior fiscal year, when revenue was $204.73M. The same year closed with a net loss of $39.65M. Profit margin runs at −15.72%. That is 14 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −1.67.

Across the 4 fiscal years on file, revenue moves from $122.29M in 2022 to $236.35M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 2.32 times revenue. On price-to-sales that is 22.2% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned +8.21%. Across 5 years the annualized return works out at −20.71%. The reported beta is 0.99. Daily returns over the trailing 8 years annualize to a volatility of 49.04%.

Growth & Income

No dividend is on file for KIDS.

The strongest complete calendar year on file is 2018 at +81.76%; the weakest is 2022 at −33.63%. Of the 8 complete calendar years on file, 3 finished higher. 2026 is still running; the price is +26.18% year to date.

Peer Comparison

OrthoPediatrics Corp. Common Stock (KIDS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
OrthoPediatrics Corp. Common Stock KIDS $585.12M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. OrthoPediatrics Corp. Common Stock has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About OrthoPediatrics Corp. Common Stock

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Visit website →